Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 | +$2.49B | |
| 2 | +$2.19B | |
| 3 | +$1.94B | |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| 1 | +$775M | |
| 2 | +$540M | |
| 3 | +$434M | |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| 1 | Technology | 22.13% |
| 2 | Healthcare | 13.23% |
| 3 | Financials | 12.31% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Lionsgate Studios
LION
$2.67B
| $22.2M | 0.02% |
2,430,110
+1,625,328
|
|
||
1002
Ford
F
$45.6B
| $22.2M | 0.02% |
1,689,902
-3,451,432
|
|
||
1003
Baxter International
BAX
$8.24B
| $22.1M | 0.02% |
1,156,466
-735,907
|
|
||
1004
Hancock Whitney
HWC
$5.08B
| $22.1M | 0.02% |
346,529
+267,649
|
|
||
|
GTM
1005
ZoomInfo Technologies
GTM
$1.7B
| $22M | 0.02% |
2,165,427
+2,083,991
|
|
||
|
ORKA
1006
Oruka Therapeutics
ORKA
$2.2B
| $22M | 0.02% |
726,118
+409,232
|
|
||
1007
Latham Group
SWIM
$619M
| $22M | 0.02% |
3,463,172
-1,156,942
|
|
||
1008
Enliven Therapeutics
ELVN
$2.32B
| $21.9M | 0.01% |
1,424,344
+263,841
|
|
||
1009
Onto Innovation
ONTO
$10.2B
| $21.9M | 0.01% |
138,766
-252,516
|
|
||
1010
Nurix Therapeutics
NRIX
$1.53B
| $21.9M | 0.01% |
1,152,930
+587,625
|
|
||
1011
ProShares UltraPro Short QQQ
SQQQ
$2.88B
| $21.9M | 0.01% |
319,015
+252,062
|
|
||
1012
Scholar Rock
SRRK
$4.89B
| $21.8M | 0.01% |
495,946
+361,336
|
|
||
1013
Avantis Emerging Markets Equity ETF
AVEM
$19.6B
| $21.7M | 0.01% |
282,322
+251,998
|
|
||
1014
Yum China
YUMC
$17.4B
| $21.7M | 0.01% |
454,049
-15,923
|
|
||
1015
Universal Display
OLED
$4.33B
| $21.5M | 0.01% |
184,196
+65,291
|
|
||
1016
BGC Group
BGC
$4.46B
| $21.5M | 0.01% |
2,407,889
+1,929,097
|
|
||
1017
YPF
YPF
$17.7B
| $21.5M | 0.01% |
593,812
-7,231
|
|
||
1018
Fair Isaac
FICO
$24B
| $21.5M | 0.01% |
12,688
-7,320
|
|
||
1019
Fluence Energy
FLNC
$1.87B
| $21.4M | 0.01% |
1,083,096
+562,071
|
|
||
1020
Parsons
PSN
$5.62B
| $21.4M | 0.01% |
346,450
-148,609
|
|
||
1021
Bitdeer Technologies
BTDR
$2.03B
| $21.3M | 0.01% |
1,901,943
+1,492,397
|
|
||
1022
Exelixis
EXEL
$10.8B
| $21.3M | 0.01% |
485,877
-154,404
|
|
||
1023
Pacira BioSciences
PCRX
$926M
| $21.2M | 0.01% |
819,768
+748,590
|
|
||
1024
Viridian Therapeutics
VRDN
$2.8B
| $21.2M | 0.01% |
679,694
+602,321
|
|
||
1025
Sable Offshore Corp
SOC
$2.72B
| $21.1M | 0.01% |
2,340,322
+1,654,009
|
|